Cultural  ||| S:0 E:9 ||| JJ
adaptation  ||| S:9 E:20 ||| NN
and  ||| S:20 E:24 ||| CC
validation  ||| S:24 E:35 ||| NN
of  ||| S:35 E:38 ||| IN
the  ||| S:38 E:42 ||| DT
Underwood ||| S:42 E:51 ||| NNP
's  ||| S:51 E:54 ||| POS
Daily  ||| S:54 E:60 ||| NNP
Spiritual  ||| S:60 E:70 ||| NNP
Experience  ||| S:70 E:81 ||| NNP
Scale--Brazilian  ||| S:81 E:98 ||| JJ
version  ||| S:98 E:106 ||| NN
This  ||| S:106 E:111 ||| DT
study  ||| S:111 E:117 ||| NN
aimed  ||| S:117 E:123 ||| VBN
to  ||| S:123 E:126 ||| TO
perform  ||| S:126 E:134 ||| VB
the  ||| S:134 E:138 ||| DT
cultural  ||| S:138 E:147 ||| JJ
adaptation  ||| S:147 E:158 ||| NN
and  ||| S:158 E:162 ||| CC
analyzing  ||| S:162 E:172 ||| VBG
the  ||| S:172 E:176 ||| DT
psychometric  ||| S:176 E:189 ||| JJ
properties  ||| S:189 E:200 ||| NNS
of  ||| S:200 E:203 ||| IN
the  ||| S:203 E:207 ||| DT
Brazilian  ||| S:207 E:217 ||| JJ
version  ||| S:217 E:225 ||| NN
of  ||| S:225 E:228 ||| IN
the  ||| S:228 E:232 ||| DT
Underwood ||| S:232 E:241 ||| NNP
's  ||| S:241 E:244 ||| POS
Daily  ||| S:244 E:250 ||| NNP
Spiritual  ||| S:250 E:260 ||| NNP
Experience  ||| S:260 E:271 ||| NNP
Scale  ||| S:271 E:277 ||| NNP
( ||| S:277 E:278 ||| -LRB-
DSES ||| S:278 E:282 ||| NNP
) ||| S:282 E:283 ||| -RRB-
.  ||| S:283 E:285 ||| .
The  ||| S:285 E:289 ||| DT
adaptation  ||| S:289 E:300 ||| NN
followed  ||| S:300 E:309 ||| VBD
the  ||| S:309 E:313 ||| DT
internationally  ||| S:313 E:329 ||| RB
recommended  ||| S:329 E:341 ||| VBN
procedures  ||| S:341 E:352 ||| NNS
and  ||| S:352 E:356 ||| CC
the  ||| S:356 E:360 ||| DT
adapted  ||| S:360 E:368 ||| JJ
version  ||| S:368 E:376 ||| NN
maintained  ||| S:376 E:387 ||| VBD
equivalence  ||| S:387 E:399 ||| VBN
to  ||| S:399 E:402 ||| TO
the  ||| S:402 E:406 ||| DT
original  ||| S:406 E:415 ||| JJ
after  ||| S:415 E:421 ||| IN
wording  ||| S:421 E:429 ||| JJ
adjustments  ||| S:429 E:441 ||| NNS
in  ||| S:441 E:444 ||| IN
five  ||| S:444 E:449 ||| CD
items ||| S:449 E:454 ||| NNS
.  ||| S:454 E:456 ||| .
In  ||| S:456 E:459 ||| IN
the  ||| S:459 E:463 ||| DT
application  ||| S:463 E:475 ||| NN
to  ||| S:475 E:478 ||| TO
179  ||| S:478 E:482 ||| CD
medical-surgical  ||| S:482 E:499 ||| JJ
patients  ||| S:499 E:508 ||| NNS
it  ||| S:508 E:511 ||| PRP
was  ||| S:511 E:515 ||| VBD
found  ||| S:515 E:521 ||| VBN
evidences  ||| S:521 E:531 ||| VBN
of  ||| S:531 E:534 ||| IN
internal  ||| S:534 E:543 ||| JJ
consistency  ||| S:543 E:555 ||| NNS
( ||| S:555 E:556 ||| -LRB-
Cronbach ||| S:556 E:564 ||| NNP
's  ||| S:564 E:567 ||| POS
alpha=0.91 ||| S:567 E:577 ||| CD
) ||| S:577 E:578 ||| -RRB-
,  ||| S:578 E:580 ||| ,
test-retest  ||| S:580 E:592 ||| JJ
reliability  ||| S:592 E:604 ||| NNS
( ||| S:604 E:605 ||| -LRB-
ICC=0.94 ||| S:605 E:613 ||| NNP
)  ||| S:613 E:615 ||| -RRB-
and  ||| S:615 E:619 ||| CC
convergent  ||| S:619 E:630 ||| JJ
validity ||| S:630 E:638 ||| NN
,  ||| S:638 E:640 ||| ,
correlating  ||| S:640 E:652 ||| VBG
with  ||| S:652 E:657 ||| IN
the  ||| S:657 E:661 ||| DT
Intrinsic  ||| S:661 E:671 ||| NNP
Religiosity  ||| S:671 E:683 ||| NNP
subscale  ||| S:683 E:692 ||| NN
of  ||| S:692 E:695 ||| IN
the  ||| S:695 E:699 ||| DT
Duke  ||| S:699 E:704 ||| NNP
Religious  ||| S:704 E:714 ||| NNP
Index  ||| S:714 E:720 ||| NNP
DUREL  ||| S:720 E:726 ||| NNP
( ||| S:726 E:727 ||| -LRB-
r=0.56 ||| S:727 E:733 ||| NNP
,  ||| S:733 E:735 ||| ,
p  ||| S:735 E:736 ||| CD
< ||| S:736 E:737 ||| SYM
0.001 ||| S:737 E:742 ||| CD
) ||| S:742 E:743 ||| -RRB-
.  ||| S:743 E:745 ||| .
Exploratory  ||| S:745 E:757 ||| JJ
factor  ||| S:757 E:764 ||| NN
analysis  ||| S:764 E:773 ||| NN
extracted  ||| S:773 E:783 ||| VBD
three  ||| S:783 E:789 ||| CD
principal  ||| S:789 E:799 ||| JJ
components  ||| S:799 E:810 ||| NNS
explaining  ||| S:810 E:821 ||| VBG
60.5 ||| S:821 E:825 ||| CD
%  ||| S:825 E:827 ||| NN
of  ||| S:827 E:830 ||| IN
the  ||| S:830 E:834 ||| DT
total  ||| S:834 E:840 ||| JJ
variance ||| S:840 E:848 ||| NN
.  ||| S:848 E:850 ||| .
The  ||| S:850 E:854 ||| DT
DSES-Brazilian  ||| S:854 E:869 ||| JJ
version  ||| S:869 E:877 ||| NN
shows  ||| S:877 E:883 ||| VBZ
evidences  ||| S:883 E:893 ||| VBN
of  ||| S:893 E:896 ||| IN
reliability  ||| S:896 E:908 ||| NN
and  ||| S:908 E:912 ||| CC
validity  ||| S:912 E:921 ||| NN
among  ||| S:921 E:927 ||| IN
hospitalized  ||| S:927 E:940 ||| JJ
patients ||| S:940 E:948 ||| NNS
.  ||| S:948 E:950 ||| .
Further  ||| S:950 E:958 ||| JJ
studies  ||| S:958 E:966 ||| NNS
are  ||| S:966 E:970 ||| VBP
needed  ||| S:970 E:977 ||| VBN
to  ||| S:977 E:980 ||| TO
confirm  ||| S:980 E:988 ||| VB
its  ||| S:988 E:992 ||| PRP$
factor  ||| S:992 E:999 ||| NN
composition  ||| S:999 E:1011 ||| NN
and  ||| S:1011 E:1015 ||| CC
to  ||| S:1015 E:1018 ||| TO
test  ||| S:1018 E:1023 ||| VB
its  ||| S:1023 E:1027 ||| PRP$
applicability  ||| S:1027 E:1041 ||| NN
in  ||| S:1041 E:1044 ||| IN
different  ||| S:1044 E:1054 ||| JJ
populations ||| S:1054 E:1065 ||| NNS
.  ||| S:1065 E:1067 ||| .
